Literature DB >> 21784895

Colonic contribution to uremic solutes.

Pavel A Aronov1, Frank J-G Luo, Natalie S Plummer, Zhe Quan, Susan Holmes, Thomas H Hostetter, Timothy W Meyer.   

Abstract

Microbes in the colon produce compounds, normally excreted by the kidneys, which are potential uremic toxins. Although p-cresol sulfate and indoxyl sulfate are well studied examples, few other compounds are known. Here, we compared plasma from hemodialysis patients with and without colons to identify and further characterize colon-derived uremic solutes. HPLC confirmed the colonic origin of p-cresol sulfate and indoxyl sulfate, but levels of hippurate, methylamine, and dimethylamine were not significantly lower in patients without colons. High-resolution mass spectrometry detected more than 1000 features in predialysis plasma samples. Hierarchical clustering based on these features clearly separated dialysis patients with and without colons. Compared with patients with colons, we identified more than 30 individual features in patients without colons that were either absent or present in lower concentration. Almost all of these features were more prominent in plasma from dialysis patients than normal subjects, suggesting that they represented uremic solutes. We used a panel of indole and phenyl standards to identify five colon-derived uremic solutes: α-phenylacetyl-l-glutamine, 5-hydroxyindole, indoxyl glucuronide, p-cresol sulfate, and indoxyl sulfate. However, compounds with accurate mass values matching most of the colon-derived solutes could not be found in standard metabolomic databases. These results suggest that colonic microbes may produce an important portion of uremic solutes, most of which remain unidentified.

Entities:  

Mesh:

Year:  2011        PMID: 21784895      PMCID: PMC3171947          DOI: 10.1681/ASN.2010121220

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  35 in total

Review 1.  Recent progress in the analysis of uremic toxins by mass spectrometry.

Authors:  Toshimitsu Niwa
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2008-11-27       Impact factor: 3.205

2.  The determination of urinary phenylacetylglutamine as phenylacetic acid. Studies on its origin in normal subjects and children with cystic fibrosis.

Authors:  J W Seakins
Journal:  Clin Chim Acta       Date:  1971-11       Impact factor: 3.786

3.  Removal of P-cresol sulfate by hemodialysis.

Authors:  Andres W Martinez; Natalie S Recht; Thomas H Hostetter; Timothy W Meyer
Journal:  J Am Soc Nephrol       Date:  2005-08-24       Impact factor: 10.121

Review 4.  Indoxyl sulfate is a nephro-vascular toxin.

Authors:  Toshimitsu Niwa
Journal:  J Ren Nutr       Date:  2010-09       Impact factor: 3.655

5.  Metabolism and excretion of methylamines in rats.

Authors:  J L Smith; J S Wishnok; W M Deen
Journal:  Toxicol Appl Pharmacol       Date:  1994-04       Impact factor: 4.219

6.  Development and reproducibility of a novel high-performance liquid-chromatography monolithic column method for the detection and quantification of trans-indolyl-3-acryloylglycine in human urine.

Authors:  Kevin Carr; Paul Whiteley; Paul Shattock
Journal:  Biomed Chromatogr       Date:  2009-10       Impact factor: 1.902

7.  The metabolism of [2-14C] indole in the rat.

Authors:  L J King; D V Parke; R T Williams
Journal:  Biochem J       Date:  1966-01       Impact factor: 3.857

8.  A gas chromatographic-mass spectrometric analysis for phenols in uremic serum.

Authors:  T Niwa; K Maeda; T Ohki; A Saito; K Kobayashi
Journal:  Clin Chim Acta       Date:  1981-02-19       Impact factor: 3.786

Review 9.  Organic acids and the uremic syndrome: protein metabolite hypothesis in the progression of chronic renal failure.

Authors:  T Niwa
Journal:  Semin Nephrol       Date:  1996-05       Impact factor: 5.299

10.  The MetaCyc database of metabolic pathways and enzymes and the BioCyc collection of pathway/genome databases.

Authors:  Ron Caspi; Tomer Altman; Joseph M Dale; Kate Dreher; Carol A Fulcher; Fred Gilham; Pallavi Kaipa; Athikkattuvalasu S Karthikeyan; Anamika Kothari; Markus Krummenacker; Mario Latendresse; Lukas A Mueller; Suzanne Paley; Liviu Popescu; Anuradha Pujar; Alexander G Shearer; Peifen Zhang; Peter D Karp
Journal:  Nucleic Acids Res       Date:  2009-10-22       Impact factor: 16.971

View more
  150 in total

Review 1.  Normal and pathologic concentrations of uremic toxins.

Authors:  Flore Duranton; Gerald Cohen; Rita De Smet; Mariano Rodriguez; Joachim Jankowski; Raymond Vanholder; Angel Argiles
Journal:  J Am Soc Nephrol       Date:  2012-05-24       Impact factor: 10.121

2.  Effect of Synbiotic Therapy on Gut-Derived Uremic Toxins and the Intestinal Microbiome in Patients with CKD.

Authors:  Nosratola D Vaziri
Journal:  Clin J Am Soc Nephrol       Date:  2016-01-15       Impact factor: 8.237

3.  Blood Microbiome Profile in CKD : A Pilot Study.

Authors:  Neal B Shah; Andrew S Allegretti; Sagar U Nigwekar; Sahir Kalim; Sophia Zhao; Benjamin Lelouvier; Florence Servant; Gloria Serena; Ravi Ishwar Thadhani; Dominic S Raj; Alessio Fasano
Journal:  Clin J Am Soc Nephrol       Date:  2019-04-08       Impact factor: 8.237

4.  Prominent accumulation in hemodialysis patients of solutes normally cleared by tubular secretion.

Authors:  Tammy L Sirich; Benjamin A Funk; Natalie S Plummer; Thomas H Hostetter; Timothy W Meyer
Journal:  J Am Soc Nephrol       Date:  2013-11-14       Impact factor: 10.121

5.  Intestinal Microbiota and Kidney Diseases.

Authors:  Ao Xie; Jie Sheng; Feng Zheng
Journal:  Chin J Integr Med       Date:  2018-04-12       Impact factor: 1.978

6.  Serum concentrations of p-cresyl sulfate and indoxyl sulfate, but not inflammatory markers, increase in incident peritoneal dialysis patients in parallel with loss of residual renal function.

Authors:  Liesbeth Viaene; Björn K I Meijers; Bert Bammens; Yves Vanrenterghem; Pieter Evenepoel
Journal:  Perit Dial Int       Date:  2013-10-31       Impact factor: 1.756

7.  Untargeted LC-MS metabolomics of bronchoalveolar lavage fluid differentiates acute respiratory distress syndrome from health.

Authors:  Charles R Evans; Alla Karnovsky; Melissa A Kovach; Theodore J Standiford; Charles F Burant; Kathleen A Stringer
Journal:  J Proteome Res       Date:  2013-12-09       Impact factor: 4.466

Review 8.  Approaches to uremia.

Authors:  Timothy W Meyer; Thomas H Hostetter
Journal:  J Am Soc Nephrol       Date:  2014-05-08       Impact factor: 10.121

Review 9.  An overview of renal metabolomics.

Authors:  Sahir Kalim; Eugene P Rhee
Journal:  Kidney Int       Date:  2016-09-28       Impact factor: 10.612

Review 10.  Gut microbiota and chronic kidney disease: evidences and mechanisms that mediate a new communication in the gastrointestinal-renal axis.

Authors:  Natalia Lucía Rukavina Mikusic; Nicolás Martín Kouyoumdzian; Marcelo Roberto Choi
Journal:  Pflugers Arch       Date:  2020-02-17       Impact factor: 3.657

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.